Talcum powder litigation centers on allegations that prolonged use of talc-based personal care products can cause or contribute to the cause of ovarian cancer, with claims primarily brought against Johnson & Johnson (J&J) under failure-to-warn and design defect theories. Though the litigation developed over decades, it accelerated in the 2010s following scientific studies and internal document disclosures, leading to coordinated proceedings in both state courts and the federal Multidistrict Litigation (MDL) in the District of New Jersey. Tens of thousands of claims have since been filed nationwide, with many proceeding to trial, including several high-profile verdicts that have significantly shaped settlement efforts.
Here in Philadelphia, there are hundreds of talc cases consolidated in the Philadelphia Court of Common Pleas in the Mass Tort Program In re: J&J Talcum Powder Ovarian Cancer Litigation, Case No. 250500612. In February 2026, the most recent Philadelphia trial, Emerson v. J&J, Case No. 190509334, resulted in a jury verdict for the plaintiff for $250,000 ($50,000 compensatory, $200,000 punitive). The verdict was the first plaintiff win in Philadelphia's talcum powder mass tort and the first anywhere since J&J's three failed bankruptcy attempts (2021–2025) froze litigation for nearly five years. The punitive award signaled a jury finding of conscious disregard for consumer safety, making Emerson an immediate benchmark heading into additional trials scheduled for the upcoming year.
Matt Leckman represents Pennsylvania women who have been diagnosed with and suffered through ovarian cancer, allegedly as a result of talc exposure. The Philadelphia consolidation stands as an important battleground in the fight against J&J, and Leckman Law continues to evaluate women’s potential talc cases from all over Pennsylvania.
Mass tort law moves fast with new injuries, rulings, and legal developments emerging every day. Stay informed with our blog.